• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Azitra Inc Common Stock (NY:AZTR)

0.1769 -0.0089 (-4.79%)
Official Closing Price Updated: 8:00 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Azitra Inc Common Stock

News headline image
Azitra to Present at BIO-Europe 2024
October 29, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
October 11, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
September 24, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
September 18, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 06, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 28, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
August 22, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 20, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
August 12, 2024
From Azitra, Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
July 25, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
July 23, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents
July 23, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Reverse Stock Split
June 27, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
May 31, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
May 17, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
May 10, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
May 09, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
April 22, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
April 18, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
March 15, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Closing of Public Offering
February 16, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Pricing of Public Offering
February 13, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US
January 16, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference
January 03, 2024
From Azitra, Inc.
Via Business Wire
News headline image
Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates
November 14, 2023
From Azitra, Inc.
Via Business Wire
News headline image
Azitra to Present at the ThinkEquity Conference
October 16, 2023
From Azitra, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap